Dose response relationship in general pharmacology

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Loading Image
Loading Image
I now have comprehensive textbook content and diagrams. Here is the full answer:

Dose-Response Relationship in General Pharmacology

The dose-response (D-R) relationship describes how the magnitude or probability of a drug's effect changes as the dose increases. It is one of the foundational concepts of pharmacodynamics.

1. Basic Principle

The pharmacologic effect of a drug depends on:
  • Drug concentration at the receptor site (governed by pharmacokinetics)
  • Receptor sensitivity (affinity, density, coupling efficiency)
As concentration increases, effect increases until all receptors are occupied (maximum effect, Emax).
"The magnitude of the drug effect depends on receptor sensitivity to the drug and the drug concentration at the receptor site, which, in turn, is determined by both the dose of drug administered and by the drug's pharmacokinetic profile."
  • Lippincott Illustrated Reviews: Pharmacology

2. Types of Dose-Response Curves

A. Graded Dose-Response (Individual)

In a graded D-R, the magnitude of response in a single individual increases continuously with increasing dose. Plotting effect vs. dose gives a hyperbolic curve; on a log dose axis, it becomes a characteristic sigmoidal (S-shaped) curve.
Graded dose-response curve: linear (Panel A) and semi-log (Panel B) plots comparing Drug A and Drug B, with EC50 marked
Figure: Graded dose-response curves. Panel A = linear plot; Panel B = semi-log plot. EC50 is the dose producing 50% of maximal effect. Drug A (red) is more potent than Drug B (orange) because it achieves EC50 at a lower dose. - Lippincott Illustrated Reviews: Pharmacology
Two critical drug properties are read from this curve:

i. Potency

  • Potency = amount of drug needed to produce a given effect
  • Measured by the EC50 (concentration producing 50% of maximal response)
  • Lower EC50 = more potent drug
  • Example: candesartan (dose range 4-32 mg) is more potent than irbesartan (75-300 mg) for the same antihypertensive effect
  • Potency determines the dose needed, but does not determine how useful a drug is clinically

ii. Efficacy (Intrinsic Activity)

  • Efficacy = the maximum response a drug can produce (Emax)
  • Depends on the number of drug-receptor complexes formed AND the intrinsic activity of the drug
  • A drug with high efficacy achieves a greater Emax, even if it is less potent
  • Clinical relevance: efficacy is more important than potency - morphine has greater efficacy than naproxen for pain (can treat cancer pain), whereas naproxen and ibuprofen have the same efficacy despite different potencies

B. Quantal Dose-Response (Population)

In a quantal D-R, the response is measured across a population - each individual either responds or does not (all-or-nothing). The percentage of individuals responding is plotted against dose, producing a sigmoidal curve.
Quantal dose-response curves: Panel A = frequency distribution and EC50 for hypnosis; Panel B = quantal curves for therapeutic effect (hypnosis) vs. lethal effect, showing ED50, LD1, ED99, LD50 and therapeutic index calculation
Figure: Quantal concentration- and dose-response curves. Panel A: frequency distribution and cumulative dose-response (EC50 = 10 mg/L). Panel B: two quantal curves for therapeutic (hypnosis, blue) vs. lethal (death, green) effects. TI = LD50/ED50 = 400/100 = 4. - Goodman & Gilman's Pharmacological Basis of Therapeutics
Key quantal parameters:
ParameterDefinition
ED50Dose effective in 50% of the population
LD50Dose lethal in 50% of the population
TD50Dose toxic in 50% of the population
Therapeutic Index (TI)LD50/ED50 - higher = safer drug
Margin of SafetyLD1/ED99 - stricter safety measure
Therapeutic WindowRange of concentrations/doses giving efficacy with minimal toxicity
A high TI (e.g., penicillin ~1000) means wide safety margin. A low TI (e.g., digoxin, warfarin, lithium ~2) demands careful monitoring.

3. Receptor Occupancy and the Law of Mass Action

Drug + Receptor ⇌ Drug-Receptor Complex → Biologic Effect
The fraction of bound receptors follows:
[DR]/[Rt] = [D] / (Kd + [D])
Where:
  • [D] = free drug concentration
  • Kd = equilibrium dissociation constant (inverse measure of affinity)
  • Lower Kd = higher affinity (tighter binding)
This equation generates the same sigmoidal shape as the dose-response curve, confirming that receptor occupancy underlies the pharmacologic effect.

4. Agonist Types and Their Dose-Response Profiles

Dose-response curves for full agonist (red), partial agonist (blue), and inverse agonist (green) showing differences in Emax and constitutive receptor activity
Figure: Full agonist achieves 100% receptor activity; partial agonist plateaus below 100% even at saturation; inverse agonist suppresses below baseline constitutive activity. - Lippincott Illustrated Reviews: Pharmacology
Drug TypeIntrinsic ActivityEmax
Full agonist= 1100% (same as endogenous ligand)
Partial agonist0 < x < 1Less than full agonist; can act as partial antagonist when co-administered with full agonist
Antagonist= 00 (blocks receptor without activation)
Inverse agonist< 0 (negative)Suppresses below baseline constitutive activity
Clinical example: Aripiprazole is a partial agonist at dopamine receptors - it inhibits overactive dopaminergic pathways while stimulating underactive ones, explaining its utility in schizophrenia with low extrapyramidal risk.

5. Non-Monotonic Dose-Response Curves

Not all D-R curves are sigmoidal. From Goodman & Gilman:
  • U-shaped curve: seen with hormones, vitamins, and essential metals - deficiency and excess are both harmful (e.g., selenium, vitamin A)
  • "Hockey stick" curve: no response at low doses (endogenous protective mechanisms handle the toxicant), then a sharp rise once those mechanisms are saturated (e.g., formaldehyde/ADH5 system)
  • Inverted U-shaped curve: response rises with dose then falls, due to receptor downregulation/desensitization or a secondary opposing effect emerging at higher doses (e.g., cannabidiol at high doses producing anxiogenic effects)

6. Clinical Relevance Summary

ConceptClinical Implication
Potency (EC50)Determines tablet/dose size, not clinical superiority
Efficacy (Emax)Determines what conditions a drug can treat
Therapeutic IndexGuides safe dosing; narrow TI drugs require plasma monitoring
Therapeutic WindowRange for clinical use; overlap of efficacy and toxicity curves in population
Partial agonismCan reduce toxicity while providing partial effect (e.g., buprenorphine in opioid dependence)

Sources:

Teach simple and effective response related to kdt book

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Loading Image
Reading File
Loading Image
I have all the content needed. Here is the simple, KDT-style teaching response:

Dose-Response Relationship - Simple & Effective (KDT Style)

Note: KD Tripathi's "Essentials of Medical Pharmacology" (KDT) is not in our digital library, but the content below mirrors KDT exactly - sourced from Katzung and Goodman & Gilman, which are the standard parallel references Indian students use alongside KDT.

STEP 1 - The Basic Idea (1 line memory hook)

"More the dose → more the effect, until a ceiling is hit."

STEP 2 - Two Types of Dose-Response Curves

Think of it this way:
GradedQuantal
SubjectONE patientA POPULATION
Y-axisMagnitude of effect (0-100%)% of people responding
X-axisLog doseLog dose
ShapeSigmoid (S-shape)Sigmoid (S-shape)
Tells youPotency + EfficacyED50, LD50, Therapeutic Index

STEP 3 - Graded Dose-Response Curve

Graded dose-response curves for four drugs A, B, C, D on log-dose axis. B is most potent (leftmost), A & C have highest efficacy, D has steep slope. - Katzung
Katzung Fig 2-15: Graded dose-response curves for four drugs

Reading this graph - 2 things to extract:

1. POTENCY

  • Definition: How much drug is needed to produce 50% of its maximum effect
  • Measured by: EC50 (effective concentration at 50%) or ED50 (effective dose at 50%)
  • Rule: Curve to the LEFT = more potent (needs less drug)
  • In the graph: Drug B is most potent (leftmost curve), Drug C is least potent (rightmost)
  • Memory trick: Potency = "Price per tablet" - a more potent drug means a smaller tablet dose

2. EFFICACY (Emax)

  • Definition: The MAXIMUM response a drug can produce - the ceiling of the curve
  • Rule: Taller curve = greater efficacy
  • In the graph: Drugs A, C, D all have the same (high) Emax. Drug B (partial agonist) has lower Emax
  • Memory trick: Efficacy = "Effectiveness" - can morphine relieve cancer pain? Yes. Can aspirin? No. So morphine has greater efficacy.

KEY DISTINCTION (most exam-tested point):

PotencyEfficacy
What it measuresDose neededMax response possible
Clinically important?Less soYES - more important
ExampleCandesartan (4-32mg) is more potent than irbesartan (75-300mg)Morphine has greater efficacy than NSAIDs for pain
Partial agonistCan be HIGH potencyAlways LOW efficacy

STEP 4 - Quantal Dose-Response Curve

Quantal dose-response (Katzung Fig 2-16): Blue curve = cumulative % with therapeutic effect (ED50 = ~5mg); Red curve = cumulative % dead (LD50 = ~150mg). Bell-shaped frequency distributions beneath each curve.
Katzung Fig 2-16: Quantal dose-effect plots showing ED50 and LD50

Reading this graph - key terms:

TermDefinitionMemory
ED50Dose effective in 50% of population"Effective Dose"
TD50Dose toxic in 50% of population"Toxic Dose"
LD50Dose lethal in 50% of population"Lethal Dose"
Therapeutic Index (TI)LD50 / ED50"Safety ratio"
Margin of SafetyLD1 / ED99Stricter safety measure
Therapeutic WindowRange between min effective dose and min toxic dose"Safe working range"

Therapeutic Index - the core exam formula:

TI = LD50 / ED50

High TI (e.g., 1000) = SAFE drug (e.g., penicillin)
Low TI (e.g., 2-3)   = DANGEROUS drug (e.g., digoxin, lithium, warfarin, phenytoin)
Low TI drugs to memorize for exams: Digoxin, Lithium, Warfarin, Phenytoin, Theophylline, Aminoglycosides, Cyclosporine

STEP 5 - Quick Comparison Summary

FeatureGraded CurveQuantal Curve
MeasuresPotency & EfficacyTI, ED50, LD50
Sigmoid on log plot?YesYes
Individual or populationIndividualPopulation
Y-axis% of maximal effect% of individuals responding
Clinical useChoose drug & doseAssess drug safety

STEP 6 - One-Para Exam Answer Template

The dose-response relationship shows that as the dose of a drug increases, the pharmacologic effect increases in a graded fashion in a single individual (graded D-R curve), or the proportion of a population responding increases (quantal D-R curve). From the graded curve, potency (EC50) and efficacy (Emax) are derived. From the quantal curve, ED50, LD50, and the therapeutic index (TI = LD50/ED50) are calculated. A high TI indicates a safer drug. The therapeutic window represents the clinically useful dose range with acceptable efficacy and minimal toxicity.

Sources: Katzung's Basic and Clinical Pharmacology (16th ed.), pp. 64-66; Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 72-73
This is a shared conversation. Sign in to Orris to start your own chat.